BrainsWay Ltd. announced on October 27, 2025, two additional minority stake strategic investments in U.S. mental health providers, bringing its total for 2025 to four. One significant agreement is with Tangient ATX Inc., a management services organization for the "Heading Health" clinic network in Texas. BrainsWay will invest $1.5 million initially, with potential for up to an additional $2.5 million via milestone-based investments.
These investments are part of BrainsWay’s broader strategic initiative to accelerate patient access to and awareness of Deep TMS Therapy. The company receives a minority position in Heading Health in the form of a preferred, annually compounding security. This strategy aims to facilitate the growth of commercial partners while BrainsWay focuses on its core scientific and technological advancements.
BrainsWay also entered into a smaller investment agreement with a rapidly growing east-coast based mental health provider, further expanding its network. These strategic transactions are designed to drive long-term shareholder value by supporting the expansion of mental health services that utilize Deep TMS technology. The company continues to execute its plan of making targeted investments in the interventional psychiatry space.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.